Key Takeaways
- The MHRA has launched an AI regulatory sandbox to enhance medicines safety and treatment development.
- HSE and System C are deploying the CareFlow Pharmacy system across hospitals in Ireland.
- Various NHS trusts in the UK are implementing new digital healthcare systems to improve patient management and safety.
New Initiatives in Healthcare Technology
The Medicines and Healthcare products Regulatory Agency (MHRA) has rolled out an AI regulatory sandbox aimed at enhancing medicines safety and speeding up new treatment development. Announced by Science Minister Lord Vallance on June 9, 2026, this initiative offers companies and researchers a controlled environment to test AI tools that can forecast medicine performance and pinpoint safety risks earlier in development. Collaborating with industry and academic partners, the MHRA aims to determine if AI can improve safety assessments and unveil risks that traditional methodologies may overlook.
In Ireland, the Health Service Executive (HSE) and System C are progressing with a national deployment of CareFlow Pharmacy across hospitals. This integrated system is now operational in nine hospitals, with plans for an additional 12 sites set to go live in 2026. A third phase beginning later this year will enhance the system’s presence in the remaining 34 hospitals, establishing a unified digital pharmacy framework across the public healthcare network. By consolidating information regarding medications, patients, prescribers, and financials, CareFlow aims to minimize waste and cut operational expenses.
In Wales, Powys Teaching Health Board has implemented Better Meds, an electronic prescribing and medicines administration system, starting with Bronllys Hospital. This is part of a phased rollout across Powys’ community hospitals and inpatient services, aligning with the wider Digital Medicines programme overseen by Digital Health and Care Wales. Notably, Powys has distinguished itself by being the first health board in Wales to utilize both read and write functionalities within the Shared Medicines Record, a comprehensive national record encompassing patients’ medication histories, allergies, and intolerances.
Additionally, University Hospitals Sussex NHS Foundation Trust has entered a contract with Alcidion to implement an electronic patient record (EPR) system, marking a significant advancement in their digital capabilities. The seven-year contract focuses on rolling out the Miya Precision platform, including the Miya Observations and Assessments module, expected to be fully operational by spring 2027.
Furthermore, University Hospitals Coventry and Warwickshire NHS Trust recently launched an interoperable digital medicines management system to enhance patient safety while easing the workload of front-line staff. This system integrates Omnicell’s automated dispensing solutions with Oracle Health’s EPR, backed by NHS England funding.
Lastly, NHS Greater Glasgow and Clyde is in the process of establishing a digital triage system within its emergency departments, part of its Virtual Hospital initiative aimed at optimizing patient flow and prioritizing urgent cases. The initial rollout commenced at the Queen Elizabeth University Hospital on June 24, 2026, followed by deployments at other significant hospitals including Royal Alexandra and Glasgow Royal Infirmary, utilizing the eConsult platform to streamline patient check-ins and assessment upon arrival at A&E.
These advancements reflect a significant move towards digitization in healthcare, improving efficiency, safety, and overall patient care across various UK health services.
The content above is a summary. For more details, see the source article.
